Industry & Innovators
We support MedTech Innovators from concept to commercialisation
We have over eight years of experience in evaluating diagnostics and medical devices, having developed a range of customised tools and approaches using a human-centred approach. We co-founded the MedCity Diagnostic Growth Hub, enabling access to an extensive network of scientists, clinicians and research infrastructure across London.
We establish stakeholder needs, map out clinical pathways and processes, and quantify the impact using health economics. We have a dedicated Patient and Public Involvement/Engagement (PPIE) team, and all our research is done in real world settings i.e. where clinicians, NHS staff and patients interact in diverse settings including primary, secondary and community health care.
We recommend innovators to come to us as early as possible so that we can help shape the development and design that optimise context of use and subsequent value to the health service. This then enables smoother commercialisation and improves adoption and implementation. We cost our support based on the research elements required (i.e. work packages.) based on the product, the evidence gaps and needs. We normally co-apply for a research grant application with innovators but we do consider other funding models.
Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/london.ivd.nihr.ac.uk/public_html/wp-content/themes/nihr/parts/content-fc-section.php on line 30
Help for Industry and Innovators
New innovations in healthcare can only make a difference once they are adopted. But before they can be used in patient care, they must be proven to be safe and effective at solving an unmet need. Innovators of all sizes must prove the efficacy and value of their new solutions through the creation of research and evidence, before they take their innovation to market.
It’s a familiar problem for innovators who often invest significant time and money in product development, only to struggle to gain market traction once launched because of the necessary evidential thresholds expected by healthcare providers before adopting a new device, technology or software solution.
Who we can help
London IVD is an expert team of researchers and academics that helps all innovators including clinical innovators, academic collaborators, SMEs and large multinational organisations.
How we can help
We help to achieve regulatory approval for new devices, technologies and software, and accelerate their adoption by the NHS. We support innovators and organisations at all stages of their product development across all care settings with:
- funding applications – take a look at the funding opportunties available for innovators
- clinical feasibility
- health economics
- human factors
- creating the evidence-base needed to support access and adoption.
Stages of development
How we support medical technology, software, device and diagnostic companies to access the NHS
We assess the feasibility and effectiveness of new diagnostics and health technologies, enabling innovators to take their product to market. Using a variety of studies and research methods we produce the evidence for innovators to accelerate their product development, sales cycle and growth.
Through our extensive clinical networks and access to world-leading hospitals, we help innovators understand and engage the most valuable people to work with to produce modelled and real-world evidence and evaluations. Our team specialises in defining new ways to collect research and undertake evaluations of new diagnostic devices, health technologies and digital solutions before they are used in real life scenarios.
We undertake the following research:
Clinical studies: Clinical studies are used to determine the safety and effectiveness of new devices and technologies in treating conditions. We support the rapid clinical evaluation of medical technologies through the design and delivery of robust clinical trials, providing access to patients and samples. Our approach includes the development of biomarker-associated interventions and randomised controlled trials.
Human factors: A human factors study explores how people interact with and experience new devices within a clincial pathway. Our experienced qualitative researchers identify key stakeholders, such as clinicians, nurses, patients, carers and NHS procurement managers, then conduct semi structured interviews and analyse the results. It involves psychology-based analyses as well as hands-on usability testing.
Health economics: We produce health economic evaluations for in vitro diagnostics (IVDs) and health technologies at all stages of development. Evaluations focus on identifying the optimal placement for a new technology within existing care pathways and describe the health and cost effectiveness of introducing a new device. Early-stage evaluations identify key drivers for cost-effectiveness and areas of uncertainty to focus future research efforts on. Later stage economic evaluations, conducted when evidence on clinical validity and clinical utility becomes available, can be used to inform commissioning or adoption decisions based on the impact on patients and the NHS.
Patient and public engagement: We support innovators looking to produce solutions for any care setting or pathway. In doing so we recognise the value of bringing together people of all ages and backgrounds with experience of the health and care system. Through patient and public engagement, we bring patients, service users, carers, and community members together from a range of groups to inform our studies.
Laboratory validation: Using laboratory validation techniques, we help innovators develop the evidence to demonstrate that a test is both analytically and clinically valid. Analytical validity refers to how well a test performs in detecting or measuring the presence of a given chemical compound, hormone, or genetic marker in a given sample. Clinical validity refers to how accurately a test predicts the presence of, or risk for, a given condition.
Data science: By applying advanced analytics techniques and scientific principles to large, and sometimes unstructured, data sets London IVD is able to help innovators extract valuable information for product development, business decision-making, and strategic planning.
Adoption: We support the adoption of new solutions through the commercialisation and dissemination of technology. We can help with event management for workshops and meetings with external partners to discuss new opportunities, the dissemination of research and results, and advice on market access and adoption.
What is it like to work with NIHR London IVD?
At London IVD, we don’t just provide turnkey evaluation services, we continuously develop and refine robust methodologies for undertaking research in healthcare settings. Traditional approaches of evaluation such as randomised control trials can take years to demonstrate the efficacy of a new solution.
Our novel methods, evidenced and refined over many years, enable our clients to prove the validity of their innovations much quicker with smaller sample sizes, while still providing a comprehensive assessment of new diagnostics, devices and technology. Our research packages are customised according to the needs and resources of each client.
We support innovators at all stages of their product development. We help those who have an idea or concept to mitigate risks and develop initial device mock-ups; we support the development of working prototypes; and we help those with a final product by generating evidence that increases the chances of adoption. While each research project is different, we suggest the following process:
- Firstly, we encourage innovators to make an enquiry using our contact form
- The information provided will help us set up a confidentiality agreement
- After a confidentiality agreement is signed, we will discuss funding options. We work with innovators on grant-funded projects, company-funded projects and academic collaborations (see details below)
- The funding model determines the structure of the project. Once this is secured, the research project will start.
Funding Opportunities for Innovators
There are a variety of funding options available to support healthcare innovators, whether you’re a clinical innovator, SME, or larger organisation. We have various different funding competitions that support healthcare diagnostics, device and technology development in the UK – take a look at our current funding opportunities below or get in touch to find out more.